Locations:
Search IconSearch

Tag: clinical trials

Genetic sequencing
September 26, 2024/Cancer

AI Can Help Find Trials for Patients with Rare Cancers

Study demonstrates potential for improving access

neurons, axons and synapses in the brain
September 5, 2024/Neurosciences/Research

A Case Study in Neurotherapeutic Clinical Trial Design and Conduct

New phase 1 trial showcases Neurological Institute’s interdisciplinary study capabilities

Large B-cell lymphoma (DLBCL)
January 18, 2024/Cancer/Blood Cancers

Trial for Patients 75 and Older with Diffuse Large B-Cell Lymphoma Helps Address Care Inequities

Multiple Cleveland Clinic sites to participate in National Cancer Institute trial comparing treatment regimens for newly diagnosed patients

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

23-NEU-3813861 multiple-sclerosis-patient_650x450

How the SPRINT-MS Follow-On Study Aims to Enhance Future Trials of Progressive Multiple Sclerosis

In search of optimal imaging biomarkers, best methods for long-term follow-up

23-NEU-3810710-CQD-Hero-650×450

Clinicians Emphasize Harm Reduction When Counseling Patients About the Use of Psychedelics

Growing public interest in hallucinogens highlights their therapeutic promise and potential perils

CAR T-cell therapy for multiple myeloma
March 13, 2023/Cancer/Blood Cancers

Ide-CEL CAR T-Cell Therapy Effective in Multiple Myeloma Among Patients with Comorbidities

Research indicates strong rationale for expanding trial eligibility criteria

DDI 774058 Viars 04-05-23
February 15, 2023/Digestive/News

Digestive Disease & Surgery Institute’s New Director of Research Outlines Vision

A three-step plan aimed at strengthening the institute’s infrastructure includes a renewed focus on mentorship

22-DDI-3348194 CQD-NEJM Colonoscopy Effectiveness Study hero
January 10, 2023/Digestive/Research

Don’t Give Up on Screening Colonoscopy

A study of the procedure’s efficacy is cause for reflection, not rejection

22-CNR-2977865-CQD-Hero-650×450
June 28, 2022/Cancer/News & Insight

The Subjective Nature of “Safe and Tolerable” Conclusions

Dr. Aaron Gerds argues for more balance in safety reporting

BackPage 1 of 4Next

Advertisement

Ad